Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Becton Dickinson (NY: BDX ) 234.33 -0.91 (-0.39%) Official Closing Price Updated: 7:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Becton Dickinson < Previous 1 2 3 4 5 6 7 8 9 Next > Price Over Earnings Overview: Becton Dickinson October 23, 2024 Via Benzinga A Glimpse Into The Expert Outlook On Becton Dickinson Through 4 Analysts October 01, 2024 Via Benzinga Medtronic Inc. Dividend Stock Analysis - Sunday, Sept. 29 September 29, 2024 Medtronic Inc. is a global medical device manufacturer with leadership positions in the pacemaker, defibrillator, orthopedic, diabetes management, and other medical markets. Here are some highlights... Via Talk Markets Top Analyst Reports For Nvidia, American Express & Wells Fargo September 27, 2024 Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp., American Express Co., and Wells Fargo & Co., as well as two micro-cap stocks Elite Pharmaceuticals, Inc.... Via Talk Markets (BDX) - Analyzing Becton Dickinson's Short Interest August 23, 2024 Via Benzinga The 3 Best Dividend Aristocrats to Buy for Sustainable Income: August 2024 August 08, 2024 Explore the best dividend payouts from leading companies for sustainable, steady and growing income streams. Via InvestorPlace Looking Into Becton Dickinson's Recent Short Interest August 07, 2024 Via Benzinga Key Takeaways From Becton Dickinson Analyst Ratings July 26, 2024 Via Benzinga Looking Into Becton Dickinson's Recent Short Interest July 17, 2024 Via Benzinga 8 Health Care Stocks With Whale Alerts In Today's Session August 01, 2024 Via Benzinga Insulin Device Maker Embecta Weighs Sale After 70% Share Decline Following Becton Dickinson Spin-Off July 23, 2024 Embecta is exploring a potential sale after a nearly 70% drop in share price since its spin-off from Becton Dickinson. The company's U.S. business has struggled with the rise of GLP-1 drugs and... Via Benzinga 3 Healthcare Stocks to Buy Now to Profit From Aging Population Trends July 11, 2024 With the baby boom turning into a retirement bonanza, investors should consider these senior-focused healthcare stocks. Via InvestorPlace Topics Retirement Exposures Pension UnitedHealth, Edwards Lifesciences, First Citizens Bank And More: CNBC's 'Final Trades' July 11, 2024 UnitedHealth Group was declared a "solid" healthcare company on CNBC. Cantor Fitzgerald analyst Sarah James maintains a price target of $591. Via Benzinga Boing! 7 Undervalued Stocks That Could Surprise the Skeptics. July 01, 2024 The market previously supported a higher multiple for these undervalued stocks, making them attractive contrarian targets. Via InvestorPlace Peering Into Becton Dickinson's Recent Short Interest June 10, 2024 Via Benzinga Looking Into Becton Dickinson's Recent Short Interest April 29, 2024 Via Benzinga Stock Market Revs To Highs On Nvidia, CrowdStrike, Yields: Weekly Review June 07, 2024 The Nasdaq and S&P 500 hit record highs, but small caps retreated. Via Investor's Business Daily Topics Stocks Exposures US Equities BD Bolsters Portfolio With $4.2B Cash Deal For Edwards Lifesciences' Critical Care Group: Details June 03, 2024 BD (Becton, Dickinson and Company) will acquire Edwards Lifesciences' Critical Care product group for $4.2 billion in cash. This acquisition enhances BD's portfolio with advanced AI-enabled monitoring... Via Benzinga Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal June 03, 2024 Edwards Lifesciences stock rallied Monday on medtech giant Becton Dickinson's plan to buy a key division for $4.2 billion. Via Investor's Business Daily Trade Winds Turning: 3 Stocks Poised to Gain from Biden’s China Tariffs May 21, 2024 Here are three potential stocks to buy that could benefit from China tariffs amidst the turning trade winds. Via InvestorPlace Topics World Trade Exposures Tariff Biden's New Tariffs On Chinese Imports Are A 'Clear Giveaway' To These Two Tesla Rivals, Jim Cramer Says: 'I Like This Policy' May 15, 2024 Jim Cramer has highlighted the potential benefits for U.S. automakers, particularly Ford and General Motors, following the Biden administration's decision to impose substantial tariffs on Chinese... Via Benzinga Topics World Trade Exposures Tariff MarketBeat Week in Review – 4/29 - 5/3 May 04, 2024 Apple, Amgen, and a weak jobs report helped move the market higher as investors temporarily looked past the possibility of no interest rate cuts in 2024 Via MarketBeat Topics Economy Stocks Exposures Interest Rates US Equities 10 Health Care Stocks Whale Activity In Today's Session May 03, 2024 Via Benzinga Becton & Dickinson 'Is Well On Its Way To Achieving 2025 Commitments,' Analyst Optimistic On Outlook May 02, 2024 BD reports Q2 sales of $5.04 billion, up 4.6% Y/Y. BD Medical, Life Sciences, and Interventional segments show growth. Guidance was raised for 2024 sales, and EPS was adjusted. William Blair rates BDX... Via Benzinga BDX Stock Earnings: Becton, Dickinson Beats EPS, Beats Revenue for Q2 2024 May 02, 2024 BDX stock results show that Becton, Dickinson beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Boston Scientific Bucks the Medtech Slow Down and Raises Outlook April 30, 2024 Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook. Via MarketBeat How Much Will $10k Invested in These Dividend Aristocrats Grow to by 2025? April 26, 2024 Curious to know how much these dividend aristocrats could grow in the next year? Here's the answer for several well-known shares. Via InvestorPlace Rich Returns at a Discount: 3 Dividend Aristocrats Trading at 52-Week Lows April 03, 2024 Want quality picks and reliable income at a discount? Check out these Dividend Aristocrats trading at 52-week lows. Via InvestorPlace AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement April 02, 2024 AngioDynamics resolves decade-long patent litigation with Becton, Dickinson in landmark settlement, streamlining legal expenses and marking a significant milestone for the company. Via Benzinga Topics Intellectual Property Exposures Intellectual Property Should You Buy Solventum (SOLV) Stock After the 3M Spinoff? April 01, 2024 Although 3M shareholders have reason to dump the Solventum spinoff, SOLV stock could be intriguing at the right price. Via InvestorPlace < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
